Ukususela ngo-Agasti 26 ukuya ku-Agasti 30, 2024, indawo yokuvelisa i-peptide ye-JYMed, i-Hubei JX Bio-Pharmaceutical Co., Ltd., iphumelele ngempumelelo uhlolo lwendawo olwenziwe yi-US Food and Drug Administration (FDA). Uhlolo lwabandakanya imimandla ephambili efana nenkqubo yomgangatho, inkqubo yemveliso, izixhobo kunye nenkqubo yoncedo, ulawulo lwelabhoratri, kunye nenkqubo yolawulo lwemathiriyeli.
Oku kuphawula uhlolo lokuqala lwe-FDA olugqitywe ngempumelelo liziko lokuvelisa i-peptide ye-Hubei JX. Ngokwengxelo yohlolo, umgangatho weziko kunye neenkqubo zemveliso zihlangabezana ngokupheleleyo nemigangatho ye-FDA.
I-JYMed idlulisa umbulelo ongazenzisiyo kwiqabane layo elinobuchule, iRochem, ngenkxaso yabo eqhubekayo ngexesha lohlolo lwe-FDA oludlulileyo nolwangoku.
Le mpumelelo ibonisa ukuba indawo yokuvelisa i-peptide ye-Hubei JX ithobela iimfuno ze-FDA zomgangatho kunye neenkqubo zemveliso, ifanelekele ukungena kwimarike yase-US.
Malunga JYMed
Yasekwa ngo-2009, iShenzhen JYMed Technology Co., Ltd. yinkampani yebiotechnology egxile kuphando oluzimeleyo, uphuhliso, imveliso, kunye nokuthengiswa kweemveliso zepeptide, ecaleni kweR&D yepeptide yesiko kunye neenkonzo zokuvelisa. Inkampani inikezela ngee-API ze-20 ze-peptide, kunye neemveliso ezintlanu, ezibandakanya i-Semaglutide kunye ne-Tirzepatide, emva kokugqiba ngempumelelo iifayili ze-US FDA DMF.
Iziko le-Hubei JX linemigca yemveliso ye-10 ye-peptide APIs (kubandakanywa nemigca ye-pilot-scale) ehambelana nemigangatho ye-cGMP yase-US, EU, ne-China. Eli ziko lisebenza ngenkqubo ebanzi yolawulo lomgangatho wamachiza kunye nenkqubo yolawulo ye-EHS (Environmental, Health, and Safety). Iphumelele uhlolo lwe-GMP olusemthethweni lwe-NMPA kunye nophicotho lwe-EHS olwenziwa ngabathengi abakhokelayo behlabathi.
Iinkonzo ezingundoqo
Ukubhaliswa kwe-API ye-peptide ye-1.Domestic kunye neyamazwe ngamazwe
2.Izilwanyana zezilwanyana kunye ne-cosmetic peptides
3.Custom peptide synthesis, CRO, CMO, kunye neenkonzo OEM
I-4.PDC (i-Peptide Drug Conjugates), kuquka i-peptide-radionuclide, i-peptide-imolekyuli encinci, i-peptide-protein, kunye ne-peptide-RNA conjugates
Iinkcukacha zoqhakamshelwano
Idilesi: 8th & 9th Floors, Building 1, Shenzhen Biomedical Innovation Industrial Park, Jin Hui Road 14, Kengzi Street, Pingshan District, Shenzhen, China
Ngemibuzo ye-API yamazwe ngamazwe:
+ 86-755-26612112 | +86-15013529272
Kwizinto ezikrwada zePeptide yokuthambisa yasekhaya:
+ 86-755-26612112 | +86-15013529272
KuBhaliso lwe-API yasekhaya kunye neeNkonzo zeCDMO:
+86-15818682250
Iwebhusayithi:www.jymedtech.com
Ixesha lokuposa: Dec-11-2024